Biogen huge earnings beat. Biotech is place to be. I wonder if RCPT will go up with the huge revs in MS market? ICPT breakthrough, I don't hold anymore bummer. Market looking better??
Those buys around and under 100 are looking good no matter. I am taking position in ACAD today. I think the recent 50 dollar price target and upgrade puts a floor around 30 and the upside to take out 52wk high with a very near term NDA announcement. The NDA has been delayed so some have lost patience but I doubt any issues and they said Q1 2015. Good luck market is not friendly.
bump GOOD Nov. Call FOOLS
I still think there is a 'damaged goods' smell, so thinking 150 - but I won't quibble if 180 shows up!
I like this very much. Certainly nothing hidden away that will deter any buyer. What do you think is the buyout at any guess? I put 180 out.
WOW for 2014 all the FUD for FOOLS was actually NOTHING : For the nine months ended September 30, 2014, this would decrease previously reported net product revenue by $0.7 million and result in no change
“The conclusion of the accounting portion of the ongoing Audit Committee review is an important milestone,” said Thomas W. D’Alonzo, Chairman of the Board of Salix. “While in total the restatements are minor in scale, the Audit Committee takes these matters very seriously and is in the process of promptly enhancing controls and procedures to ensure this never happens again.”
Audit Committee Determines to Restate Financial Statements for FY2013 and First Three Quarters of 2014
*Aggregate impact of errors on net product revenue and net income over all previously reported periods affected by the restatements is a decrease of approximately $20.7 million and $11.9 million, respectively
*Audit Committee and Company presently do not expect to identify any other material adjustments